Drug Delivery Strategies for the Treatment of Metabolic Diseases

被引:39
|
作者
Shi, Sanjun [1 ,2 ,3 ]
Kong, Na [1 ,2 ,3 ]
Feng, Chan [1 ,2 ,3 ]
Shajii, Aram [1 ,2 ,3 ]
Bejgrowicz, Claire [1 ,2 ,3 ]
Tao, Wei [1 ,2 ,3 ]
Forokhzad, Omid C. [1 ,2 ,3 ]
机构
[1] Brigham & Womens Hosp, Ctr Nanomed, 75 Francis St, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Dept Anesthesiol, 75 Francis St, Boston, MA 02115 USA
[3] Harvard Med Sch, Boston, MA 02115 USA
关键词
biomaterials; drug delivery; metabolic diseases; nanomedicine; LOOP INSULIN DELIVERY; ONE-POT SYNTHESIS; ORAL DELIVERY; POLYMERIC NANOPARTICLES; CONTROLLED-RELEASE; MODIFIED LEPTIN; GLUCOSE; OBESITY; INFLAMMATION; MECHANISMS;
D O I
10.1002/adhm.201801655
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Metabolic diseases occur when normal metabolic processes are disrupted in the human body, which can be congenital or acquired. The incidence of metabolic diseases worldwide has reached epidemic proportions. So far, various methods including systemic drug therapy and surgery are exploited to prevent and treat metabolic diseases. However, current pharmacotherapeutic options for treatment of these metabolic disorders remain limited and ineffective, especially reducing patient compliance to treatment. Therefore, it is desirable to exploit effective drug delivery approaches to effectively treat metabolic diseases and reduce side effects. This brief review summarizes novel delivery strategies including local, targeted, and oral drug delivery strategies, as well as intelligent stimulus-responsive drug delivery strategy, for the treatment of metabolic disorders including diabetes, obesity, and atherosclerosis.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] Innovative Nanotechnology in Drug Delivery Systems for Advanced Treatment of Posterior Segment Ocular Diseases
    Wu, Yue
    Li, Xin
    Fu, Xueyu
    Huang, Xiaomin
    Zhang, Shenrong
    Zhao, Nan
    Ma, Xiaowei
    Saiding, Qimanguli
    Yang, Mei
    Tao, Wei
    Zhou, Xingtao
    Huang, Jinhai
    ADVANCED SCIENCE, 2024, 11 (32)
  • [32] A Review of Implantable Intravitreal Drug Delivery Technologies for the Treatment of Posterior Segment Eye Diseases
    Choonara, Yahya E.
    Pillay, Viness
    Danckwerts, Michael P.
    Carmichael, Trevor R.
    Du Toit, Lisa C.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 99 (05) : 2219 - 2239
  • [33] Nanoparticle-Mediated Drug Delivery for the Treatment of Cardiovascular Diseases
    Pala, Rajasekharreddy
    Anju, V. T.
    Dyavaiah, Madhu
    Busi, Siddhardha
    Nauli, Surya M.
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2020, 15 : 3741 - 3769
  • [34] Recent Developments in Nanomaterials-Based Drug Delivery and Upgrading Treatment of Cardiovascular Diseases
    Mohamed, Nura A.
    Marei, Isra
    Crovella, Sergio
    Abou-Saleh, Haissam
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (03)
  • [35] Drug delivery strategies and systems for HIV/AIDS pre-exposure prophylaxis and treatment
    Nelson, Antoinette G.
    Zhang, Xiaoping
    Ganapathi, Usha
    Szekely, Zoltan
    Flexner, Charles W.
    Owen, Andrew
    Sinko, Patrick J.
    JOURNAL OF CONTROLLED RELEASE, 2015, 219 : 669 - 680
  • [36] Nanomedicine and drug delivery strategies for treatment of inflammatory bowel disease
    Takedatsu, Hidetoshi
    Mitsuyama, Keiichi
    Torimura, Takuji
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (40) : 11343 - 11352
  • [37] Exosomes as potential drug delivery tools for treatment of cardiovascular diseases
    Xi-yong YU
    Song-pei LI
    中国药理学与毒理学杂志, 2018, 32 (04) : 327 - 328
  • [38] Nanomedicine and drug delivery strategies for treatment of inflammatory bowel disease
    Hidetoshi Takedatsu
    Keiichi Mitsuyama
    Takuji Torimura
    World Journal of Gastroenterology, 2015, (40) : 11343 - 11352
  • [39] Innovative drug delivery strategies to the CNS for the treatment of multiple sclerosis
    Mwema, Ariane
    Muccioli, Giulio G.
    des Rieux, Anne
    JOURNAL OF CONTROLLED RELEASE, 2023, 364 : 435 - 457
  • [40] Engineered nanomaterials enhance drug delivery strategies for the treatment of osteosarcoma
    Zhang, Haorui
    Luo, Ping
    Huang, Xiaojun
    FRONTIERS IN PHARMACOLOGY, 2023, 14